Get the latest Venture Capital & Angel investors news and info Join Our Mailing List:

Your Name: 

Your Email:  

*By submitting your name & email you agree to receive for FREE our scholarships & offers Newsletters. You agree also with the storage and handling of your data by this website and 3rd party email services.
You may unsubscribe if you wish. And you can delete your email and name at any time by emailing us to the email on the bottom of this page.

Follow us on

Visit the Business Grant Funding.Net site

Business Grant Funding.Net
 
  • Artificial Muscle, Inc. Secures $20 Million Series B Round

    June 7th, 2007 No comments

    Artificial Muscle, Inc., (AMI) a manufacturer that designs and builds actuator components based on its patented electro active polymer artificial muscle (EPAM™) technology, recently announced a $20 million Series B round of financing. AMI will use the funds for ramping up its high volume manufacturing and operations, new product development, and marketing and sales resources to support the plan for initial product launches.

    The round was led by the venture capital division of AllianceBernstein L.P., a leading asset management firm headquartered in New York. All Series A round investors participated in the Series B round including Arch Venture Partners, NGEN Partners, and Vanguard Ventures. Also investing in the Series B round were key strategic investors including Micron Technology, Inc.; Parker Hannifin Corporation; and CTTV Investments LLC, the venture capital arm of Chevron Technology Ventures.

    AMI also announced the appointment of Scott Metcalf as COO and Vice President of Manufacturing. Mr. Metcalf brings extensive manufacturing knowledge and an executive management background to the company. Previously he had served as CEO of Pathscale and Hal Computer Systems and in key manufacturing executive positions at Sun Microsystems.

    “We are delighted with the addition of AllianceBernstein L.P. as an investor as well as the continued support of our Series A round investors,” said Art Goldberg, AMI’s President and CEO. “They and our new corporate investors share our confidence that AMI’s Electroactive Polymer Artificial Muscle (EPAM) technology and products will introduce a revolutionary change in the $50B global actuator market. We are also very fortunate to have Scott Metcalf on board to lead our ramp to high volume EPAM actuator manufacturing”

    “We see AMI’s EPAM technology as a truly disruptive actuator technology,” remarked Jamie Kiggen, Senior Vice President of AllianceBernstein L.P. “We are excited about the breadth of AMI’s product roadmap, including applications from lens actuators on cell phone cameras to a wide variety of industrial pump, valve, sensor, and transducer solutions.”

    Artificial Muscle, Inc. (AMI) is a high technology company that designs and manufactures actuator and sensing components based on the new technology platform called electroactive polymer artificial muscle (EPAM). EPAM technology is called artificial muscle because of the context of its historical development and because, much like human muscle, it converts one form of energy (electrical field energy) into mechanical motion. It offers significant advantages over typical electromagnetic-based technologies because it is much lighter, smaller, quieter and cheaper, and offers more controllable and flexible configurations. EPAM devices serve as lightweight, highly efficient alternatives to actuators, small motors, generators, sensors, and speakers used in products ranging from automobiles to audio speakers. AMI serves a multi-billion dollar market with artificial muscle-based components for consumer, medical, industrial, automotive, aerospace and cleantech applications.

    AMI was founded by SRI International, which is a Silicon Valley non-profit research and development institute that has a history of 50 years of developing advanced technologies, to exclusively commercialize artificial muscle technology. EPAM technology was developed at SRI over a 12-year period. AMI became an independent company in early 2004 with venture fund financing from Vanguard Ventures, ARCH Venture Partners, and NGEN Partners.

    For more information, please visit www.artificialmuscle.com

Leave a reply

Please leave these two fields as-is:

Protected by Invisible Defender. Showed 403 to 250,578 bad guys.

 

Latest Headlines:

Friday August 31, 2012
Zscaler Secures $38 Million Investment Round


Wednesday November 30, 2011
Health Care Solutions companies Infinity Pharmaceutics, NanoVobronix and Selventa raise funds.


Monday November 21, 2011
Panda Power opens $420 Million Fund for Solar and Natural Gas Projects


Thursday November 17, 2011
Better Place raises $200 Million for Electric Cars in the Series C of Funding


Wednesday November 16, 2011
Accel Partners raise $100 Million Big Data Fund to Invest in Hadoop, NoSQL and other Companies


Tuesday November 15, 2011
Skimlinks raises $4.5 Million to help Bloggers Increase their Gains


Monday November 14, 2011
Standing Cloud raises $3 Million to help New Cloud Providers grow Faster


Thursday November 10, 2011
Zillow acquires Diverse Solutions for $7.8 to help Real Estate Agents increase their Visibility


 

By using this website you agree with our cookie policy